assignment and ASSUMPTION AGREEEMENT and Amendment No. 3 to the exclusive license (amended and restated) AgreementAssignment and Assumption Agreement and Amendment No. 3 to the Exclusive License (Amended and Restated) Agreement • August 10th, 2020 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • California
Contract Type FiledAugust 10th, 2020 Company Industry JurisdictionThis Assignment and Assumption Agreement and Amendment No. 3 to the Exclusive License (Amended and Restated) (“Agreement”), entered into as of June 11, 2020 (“Effective Date”), is made by and among The Board of Trustees of the Leland Stanford Junior University, ("Stanford"), an institution of higher education having powers under the laws of the State of California; Trigemina, Inc. ("Trigemina"), a corporation having a principal place of business at 1036 Country Club Drive, Suite 200, Moraga, California 94556; and Tonix Pharmaceuticals, Inc., a corporation having a principal place of business at 509 Madison Avenue, Suite 306, New York, NY 10022 (“Tonix” and, together with Trigemina and Stanford, the “Parties”, and each of Tonix, Trigemina, and Stanford, a “Party”).